Thus, while impairment of the insulin signal along the IRS/PI3K pathway can explain the untoward metabolic impact of insulin resistance, the preserved response of the MAPK pathway in the presence of hyperinsulinemia might result in preserved or even increased ancillary, nonmetabolic effects of insulin [26]. This evidence concerns the gene INS and hyperinsulinism.